Correct, I would suggest that in my industry, lowering the corporate tax rate has been an advantage. Unfortunately, we've seen some cyclical changes in the pharmaceutical industry. We've seen significant revenue reductions, but the incentives provided by this government and that continue to be provided around research and development have allowed us to continue with investment in innovation and jobs.
On October 27th, 2014. See this statement in context.